文献速递流行病学与生物统计真实世界研究与卫生经济

推导研究中的最优采样与心衰预后模型外部验证判别力改善相关

Optimal sampling in derivation studies was associated with improved discrimination in external validation for heart failure prognostic models.
PubMed 文献 · J Clin Epidemiol · 2020-01-29

该研究系统检索心衰预后模型,在3452例连续急性心衰患者队列中检验其预测30天死亡的外部性能。共从6354项合格研究中识别224个模型,队列平均c统计量为0.64(标准差0.07)。仅最优采样(采样框架与招募细节的充分有效描述)与高性能相关(标准化β=0.25,95%CI 0.12–0.38,P<0.001),校正后仍显著(标准化β=0.24,95%CI 0.07–0.40,P=0.01)。

要点

  • 推导研究的最优采样是心衰预后模型外部效度的关键决定因素。
  • 队列平均c统计量为0.64,外部判别力总体有限。
  • 采样框架与招募细节的充分描述与模型外部性能独立相关。

核心结论

  • 推导研究中反映目标人群与研究人群差距的最优采样是心衰预后模型外部效度的关键决定因素。

研究设计与样本

  • 系统检索报告心衰预后模型的研究,并在3452例连续急性心衰患者队列中检验其预测30天死亡的外部性能。
  • 从6354项合格研究中识别224个模型,应用已发表的批判性评价工具分析推导研究偏倚或特征与模型性能的关系。

主要发现

  • 队列中模型平均c统计量为0.64(标准差0.07)。
  • 单变量分析中仅最优采样(总分范围0–2,评分越高偏倚风险越低)与高性能相关(标准化β=0.25,95%CI 0.12–0.38,P<0.001)。
  • 校正数据来源、研究规模、疾病阶段和研究年份等相关特征后,最优采样仍显著相关(标准化β=0.24,95%CI 0.07–0.40,P=0.01)。

临床怎么用

  • 在选用心衰预后模型时,应关注推导研究是否对采样框架和招募细节进行了充分有效描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of the study was to identify determinants of external validity of prognostic models. STUDY DESIGN AND SETTING: We systematically searched for studies reporting prognostic models of heart failure (HF) and examined their performance for predicting 30-day death in a cohort of consecutive 3,452 acute HF patients. We applied published critical appraisal tools and examined whether bias or other characteristics of original derivation studies determined model performance. RESULTS: We identified 224 models from 6,354 eligible studies. The mean c-statistic in the cohort was 0.64 (standard deviation, 0.07). In univariable analyses, only optimal sampling assessed by an adequate and valid description of the sampling frame and recruitment details to collect the population of interest (total score range: 0-2, higher scores indicating lower risk of bias) was associated with high performance (standardized β = 0.25, 95% CI: 0.12 to 0.38, P < 0.001). It was still significant after adjustment for relevant study characteristics, such as data source, scale of study, stage of illness, and study year (standardized β = 0.24, 95% CI: 0.07 to 0.40, P = 0.01). CONCLUSION: Optimal sampling representing the gap between the population of interest and the studied population in derivation studies was a key determinant of external validity of HF prognostic models.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Iwakami N, Nagai T, Furukawa TA, et al. Optimal sampling in derivation studies was associated with improved discrimination in external validation for heart failure prognostic models. J Clin Epidemiol. 2020. PMID: 32004670. doi:10.1016/j.jclinepi.2020.01.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。